Kexing BiopharmEN
Home / R&D and Innovation / R&D field
R&D and Innovation
Gain insight into the needs of doctors and patients, firmly develop and innovate

Devoted to the life sciences with persistence, Kexing Biopharm has focused on the innovation and industrialization of  biopharmaceuticals,and established a relatively complete system of pharmaceutical R&D, covering pharmaceutical innovation capabilities from pharmaceutical discovery, pharmaceutical research, preclinical research and clinical research to industrialized production.

At present, we have obtained 45 patents, An R&D team of more than 200 personnel (53.85% of them possess a master's degree or above).

Product Pipeline
Preclinical study
IND Application
Clinical Study
NDA submission
Recombinant human α2b Interferon spray
Recombinant human α2b Interferon effervescent capsule
Recombinant human α2b Interferon spray
SHEN26 COVID-19 oral capsules
Oncology Immunology
Long-acting recombinant human G-CSF
Recombinant monoclonal antibody for cancer cachexia
Bispecific antibody for solid tumor
Recombinant monoclonal antibody for Gastrointestinal Tumors
Degene rative disease
Bispecific antibody for ocular fundus
Bispecific antibody for Atopic Dermatitis
Monoclonal antibody for Systemic Lupus Erythematosus
Monoclonal antibody for Ulcerative Colitis
Recombinant human growth hormone
Long-acting recombinant human growth hormone
Exosome vehicle drug delivery
Recombinant human Type III Collagen